8-KLeadership ChangesRegulation FDExhibits & Filings

QUEST DIAGNOSTICS INC 8-K Report, Executive Changes (Jul 17, 2013)

Filed July 17, 2013For Securities:DGX

Summary

Quest Diagnostics Incorporated (DGX) announced a key leadership change in its finance department via an 8-K filing on July 17, 2013. The company appointed Mark J. Guinan as its new Senior Vice President and Chief Financial Officer (CFO), effective July 29, 2013. This appointment signals a significant investment in financial leadership, bringing in an executive with extensive experience from major corporations like Hill-Rom Holdings, Johnson & Johnson, and Proctor & Gamble. Mr. Guinan's compensation package reflects the company's commitment to attracting and retaining top talent, including a substantial base salary, performance-based incentives, and significant equity awards. The onboarding package also includes provisions to offset potential financial forfeitures from his previous employer, demonstrating a strategic approach to securing experienced financial stewardship. Investors should view this as a positive development, indicating the company's focus on strengthening its financial operations and strategic direction.

Key Highlights

  • 1Quest Diagnostics appointed Mark J. Guinan as Senior Vice President and Chief Financial Officer, effective July 29, 2013.
  • 2Mr. Guinan brings extensive financial leadership experience from previous roles at Hill-Rom Holdings, Johnson & Johnson, and Proctor & Gamble.
  • 3His annual base salary will be $550,000, with eligibility for annual incentive compensation targeting 90% of base salary.
  • 4A significant equity award with a target value of $2,000,000 will be granted, comprising stock options, performance shares, and restricted stock units.
  • 5The company is providing a $250,000 cash payment and $1,500,000 in restricted stock units as a sign-on inducement to compensate for forfeited benefits from his prior employer.
  • 6Mr. Guinan will be subject to the company's Executive Share Ownership Guidelines, requiring him to hold shares equivalent to four times his base salary.
  • 7The appointment was announced via a press release on July 17, 2013, which is furnished as an exhibit to the 8-K filing.

Frequently Asked Questions

Mark J. Guinan has been appointed as the new Senior Vice President and Chief Financial Officer (CFO) of Quest Diagnostics, effective July 29, 2013.

Mr. Guinan will receive an annual base salary of $550,000, with a target annual incentive of 90% of his base salary. He will also receive significant equity awards, including a $2,000,000 initial grant and a $1,500,000 'make whole' grant of restricted stock units, plus a $250,000 cash payment.

The 'make whole' cash payment and restricted stock units are intended to compensate Mr. Guinan for certain financial forfeitures incurred upon leaving his previous employer, serving as an inducement for him to join Quest Diagnostics.

Yes, Mr. Guinan will be required to comply with Quest Diagnostics' Executive Share Ownership Guidelines, which mandate a minimum shareholding equivalent to four times his base salary.